NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
53.02
Dollar change
+0.68
Percentage change
1.30
%
Index- P/E- EPS (ttm)-5.50 Insider Own1.50% Shs Outstand188.59M Perf Week-1.83%
Market Cap10.00B Forward P/E144.92 EPS next Y0.37 Insider Trans-0.11% Shs Float185.75M Perf Month-8.29%
Enterprise Value11.75B PEG- EPS next Q-0.13 Inst Own97.57% Short Float5.74% Perf Quarter19.74%
Income-1019.84M P/S3.54 EPS this Y90.85% Inst Trans0.18% Short Ratio3.77 Perf Half Y-12.72%
Sales2.83B P/B4.17 EPS next Y171.51% ROA-16.87% Short Interest10.67M Perf YTD-5.64%
Book/sh12.71 P/C12.72 EPS next 5Y- ROE-36.89% 52W Range39.97 - 72.83 Perf Year28.28%
Cash/sh4.17 P/FCF51.52 EPS past 3/5Y-17.13% -54.24% ROIC-20.82% 52W High-27.20% Perf 3Y42.76%
Dividend Est.- EV/EBITDA486.93 Sales past 3/5Y16.01% 25.78% Gross Margin69.57% 52W Low32.65% Perf 5Y-40.53%
Dividend TTM- EV/Sales4.16 EPS Y/Y TTM-315.25% Oper. Margin-6.75% Volatility1.13% 1.52% Perf 10Y99.70%
Dividend Ex-Date- Quick Ratio2.38 Sales Y/Y TTM11.57% Profit Margin-36.06% RSI (14)45.96 Recom1.43
Dividend Gr. 3/5Y- - Current Ratio2.73 EPS Q/Q10.37% SMA20-3.82% Beta0.98 Target Price69.39
Payout- Debt/Eq1.06 Sales Q/Q10.86% SMA502.89% Rel Volume1.33 Prev Close52.34
Employees7000 LT Debt/Eq1.04 EarningsMay 01 AMC SMA200-5.02% Avg Volume2.83M Price53.02
IPOJan 31, 2001 Option/ShortYes / Yes EPS/Sales Surpr.-44.04% 2.63% Trades Volume3,776,149 Change1.30%
Date Action Analyst Rating Change Price Target Change
Apr-10-25Initiated Mizuho Outperform $60
Mar-13-25Initiated RBC Capital Mkts Sector Perform $52
Jan-23-25Initiated Barclays Overweight $70
Aug-28-24Initiated Wells Fargo Overweight $75
Jun-27-24Initiated Scotiabank Sector Outperform $70
Jun-03-24Resumed Jefferies Buy $75
Jan-02-24Upgrade The Benchmark Company Hold → Buy $91
Dec-14-23Initiated Guggenheim Buy $90
Dec-13-23Initiated Wolfe Research Outperform $95
Oct-10-23Upgrade Piper Sandler Neutral → Overweight $90
Jun-20-25 08:41AM
Jun-19-25 09:45AM
Jun-18-25 08:43PM
Jun-12-25 06:20AM
Jun-11-25 11:36PM
08:42AM Loading…
Jun-09-25 08:42AM
Jun-05-25 11:30AM
08:52AM
Jun-04-25 05:31AM
May-28-25 06:05AM
May-27-25 04:05PM
May-22-25 05:05PM
May-20-25 07:40AM
May-19-25 07:38PM
May-16-25 06:29AM
12:38AM Loading…
12:38AM
May-14-25 04:51AM
May-12-25 10:00AM
08:44AM
May-07-25 04:55AM
May-05-25 12:55PM
May-02-25 12:52PM
12:51PM
07:28AM
06:00AM
03:18AM
May-01-25 08:47PM
05:35PM
04:36PM
04:05PM
04:05PM Loading…
04:05PM
Apr-30-25 08:50AM
Apr-29-25 06:59AM
Apr-28-25 10:00AM
Apr-24-25 10:01AM
08:08AM
05:03AM
Apr-23-25 08:50AM
Apr-22-25 06:00AM
Apr-17-25 04:15PM
Apr-15-25 05:02AM
Apr-14-25 03:00PM
06:00AM
Apr-01-25 06:00AM
Mar-31-25 06:00AM
Mar-30-25 07:10AM
03:25AM
Mar-29-25 12:20AM
Mar-27-25 09:06AM
Mar-26-25 11:10AM
Mar-24-25 12:35PM
Mar-21-25 11:30AM
Mar-20-25 09:03AM
08:50AM
Mar-19-25 04:10PM
Mar-14-25 09:01AM
Mar-12-25 09:00AM
Mar-04-25 09:00AM
Mar-03-25 06:48PM
Feb-24-25 12:00PM
06:00AM
Feb-20-25 07:01PM
01:40PM
08:25AM
02:12AM
12:30AM
Feb-19-25 05:25PM
04:42PM
04:22PM
04:05PM
Feb-18-25 08:03AM
Feb-12-25 05:57PM
10:00AM
Feb-06-25 08:30AM
Feb-03-25 06:00AM
Jan-22-25 07:39AM
Jan-21-25 05:05PM
05:05PM
04:03PM
Jan-17-25 06:15AM
Jan-16-25 09:15PM
04:05PM
05:22AM
Jan-12-25 07:00PM
Jan-03-25 06:46AM
Jan-02-25 06:00AM
Nov-26-24 07:27PM
01:24PM
06:00AM
Nov-25-24 05:35PM
Nov-19-24 06:57PM
Nov-15-24 07:47AM
Nov-13-24 01:00PM
Nov-11-24 09:55AM
Nov-08-24 06:46AM
Nov-07-24 04:05PM
10:05AM
Nov-06-24 04:04PM
11:47AM
10:22AM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zanotti Katherine SDirectorJun 13 '25Sale53.203,207170,61272,759Jun 16 05:30 PM
Zanotti Katherine SDirectorJun 13 '25Proposed Sale53.203,207170,612Jun 13 09:50 AM
Bloomer AaronEVP, Chief Financial OfficerApr 15 '25Option Exercise0.0024,460019,340Apr 17 04:30 PM
Conroy Kevin TPresident and CEOMar 07 '25Option Exercise22.3866,7231,493,2611,203,269Mar 10 05:00 PM
Herriott JamesSVP, General Counsel & SecFeb 28 '25Option Exercise0.004,265016,339Mar 04 04:48 PM
Conroy Kevin TPresident and CEOFeb 28 '25Option Exercise0.0040,31001,146,965Mar 04 04:47 PM
Baranick BrianEVP, GM, Precision OncologyFeb 28 '25Option Exercise0.009,673025,106Mar 04 04:44 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 28 '25Option Exercise0.009,673027,728Mar 04 04:40 PM
Condella SarahEVP, Human ResourcesFeb 28 '25Option Exercise0.007,738084,399Mar 04 04:37 PM
Condella SarahEVP, Human ResourcesFeb 25 '25Option Exercise0.003,954080,297Feb 26 08:00 PM
Baranick BrianEVP, GM, Precision OncologyFeb 25 '25Option Exercise0.003,954019,841Feb 26 08:00 PM
Herriott JamesSVP, General Counsel & SecFeb 25 '25Option Exercise0.001,647013,738Feb 26 08:00 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 25 '25Option Exercise0.003,954022,136Feb 26 08:00 PM
Conroy Kevin TPresident and CEOFeb 25 '25Option Exercise0.0013,18001,121,378Feb 26 08:00 PM
Conroy Kevin TPresident and CEOFeb 19 '25Option Exercise0.0010,37401,084,565Feb 21 04:30 PM
COWARD D SCOTTDirectorFeb 19 '25Option Exercise0.002,248052,831Feb 21 04:30 PM
ORVILLE JACOB AEVP, GM, ScreeningFeb 19 '25Option Exercise0.002,248016,688Feb 21 04:30 PM
Baranick BrianEVP, GM, Precision OncologyFeb 19 '25Option Exercise0.001,729014,487Feb 21 04:30 PM
Condella SarahEVP, Human ResourcesFeb 19 '25Option Exercise0.002,248074,859Feb 21 04:30 PM
Herriott JamesSVP, General Counsel & SecFeb 19 '25Option Exercise0.00865010,731Feb 21 04:30 PM
Conroy Kevin TPresident and CEONov 13 '24Buy51.3519,5001,001,3251,074,191Nov 13 12:56 PM
Baranick BrianEVP, GM, Precision OncologyOct 08 '24Sale70.0092965,03012,758Oct 09 05:00 PM
Baranick BrianOfficerOct 08 '24Proposed Sale70.0092965,030Oct 08 01:27 PM
Baranick BrianEVP, GM, Precision OncologySep 18 '24Sale70.0092965,03013,687Sep 19 05:00 PM
Baranick BrianOfficerSep 18 '24Proposed Sale70.0092965,030Sep 18 04:15 PM
Baranick BrianEVP, GM, Precision OncologyAug 05 '24Option Exercise0.002,712015,991Aug 06 05:30 PM